GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ningbo Menovo Pharmaceutical Co Ltd (SHSE:603538) » Definitions » Pre-Tax Income

Ningbo Menovo Pharmaceutical Co (SHSE:603538) Pre-Tax Income : ¥95 Mil (TTM As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Ningbo Menovo Pharmaceutical Co Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Ningbo Menovo Pharmaceutical Co's pretax income for the three months ended in Mar. 2025 was ¥29 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2025 was ¥95 Mil. Ningbo Menovo Pharmaceutical Co's pretax margin was 10.45%.

During the past 13 years, Ningbo Menovo Pharmaceutical Co's highest Pretax Margin was 26.37%. The lowest was 0.65%. And the median was 15.10%.


Ningbo Menovo Pharmaceutical Co Pre-Tax Income Historical Data

The historical data trend for Ningbo Menovo Pharmaceutical Co's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ningbo Menovo Pharmaceutical Co Pre-Tax Income Chart

Ningbo Menovo Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 204.92 180.29 384.16 7.96 86.96

Ningbo Menovo Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.42 7.37 54.71 4.46 28.88

Competitive Comparison of Ningbo Menovo Pharmaceutical Co's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Ningbo Menovo Pharmaceutical Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ningbo Menovo Pharmaceutical Co's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ningbo Menovo Pharmaceutical Co's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Ningbo Menovo Pharmaceutical Co's Pre-Tax Income falls into.


;
;

Ningbo Menovo Pharmaceutical Co Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Ningbo Menovo Pharmaceutical Co's Pretax Income for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=144.908+0+-48.271+7.967+-17.64
=87

Ningbo Menovo Pharmaceutical Co's Pretax Income for the quarter that ended in Mar. 2025 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=28.527+0+-10.351+5.277+5.43
=29

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥95 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ningbo Menovo Pharmaceutical Co  (SHSE:603538) Pre-Tax Income Explanation

Ningbo Menovo Pharmaceutical Co's Pretax Margin for the quarter that ended in Mar. 2025 is calculated as

Pretax Margin=Pretax Income/Revenue
=28.883/276.483
=10.45%

During the past 13 years, Ningbo Menovo Pharmaceutical Co's highest Pretax Margin was 26.37%. The lowest was 0.65%. And the median was 15.10%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ningbo Menovo Pharmaceutical Co Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Ningbo Menovo Pharmaceutical Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Ningbo Menovo Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.999,Yangfan Road, Room 1406, No.1, High-tech Zone, Ningbo, CHN, 315040
Ningbo Menovo Pharmaceutical Co Ltd is a China-based company is engaged in the research and development, pilot, production and sales of pharmaceutical intermediates, APIs and finished drugs. Its products line includes cardiovascular, central nervous, respiratory, anti-tumor, anti-infective, digestive system, geriatric diseases and anti-viral systems.
Executives
Xu Jian senior management
Cao Qian Director
Yao Fang Director
Ying Gao Feng Director
Sun Yan Director
Shi Jian Xiang Director
Wu Feng Yun Director
Tu Ying Director
Yao Cheng Zhi Director
Zheng Hui Lin Supervisors
Jiao Hua senior management

Ningbo Menovo Pharmaceutical Co Headlines

No Headlines